Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer (Q33333561)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer |
scientific article |
Statements
1 reference
Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer (English)
1 reference
A M Gillespie
1 reference
T J Broadhead
1 reference
S Y Chan
1 reference
J Owen
1 reference
A P Farnsworth
1 reference
M Sopwith
1 reference
R E Coleman
1 reference
1 June 2000
1 reference
1 reference
11
1 reference
735-741
1 reference
Identifiers
1 reference
1 reference